Oseltamivir Zentiva (Oseltamivir Phosphate)

Oseltamivir Phosphate, the active ingredient in Oseltamivir Zentiva, is a neuraminidase inhibitor presented as an oral tablet for oral use. It treats influenza A and B infections and can be used for prophylaxis in adults and children at risk of exposure. It is indicated for the treatment of uncomplicated influenza and for post‑exposure prophylaxis, helping to reduce symptom severity and transmission.

GNH USA supplies Oseltamivir Zentiva as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Oseltamivir Zentiva is used within the antiviral drug class to target influenza viruses. - Influenza A infection: reduces duration of symptoms and accelerates recovery. - Influenza B infection: shortens illness course and lessens fever. - Influenza prophylaxis: prevents infection in individuals exposed to the virus.

Oseltamivir Zentiva may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional emesis. - Headache: transient cranial discomfort. - Diarrhea: loose stools. - Abdominal pain: mild cramping. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, or angioedema. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Neuropsychiatric events: confusion, delirium, or abnormal behavior. - Hepatic injury: elevated liver enzymes or hepatitis. - Anaphylaxis: life‑threatening systemic allergic response.

Before prescribing Oseltamivir Zentiva, clinicians should consider several safety considerations. - Renal function: assess kidney performance and adjust dose if impairment is present. - Neuropsychiatric monitoring: observe for abnormal behavior, especially in children and adolescents. - Concomitant medications: review for drugs that may interact or alter efficacy. - Pregnancy: use only if benefits outweigh potential risks, as data are limited. - Hypersensitivity: discontinue immediately if allergic reaction occurs. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Oseltamivir Zentiva can interact with other medicines, affecting its concentration or therapeutic effect.

Major Interactions (Avoid): - Probenecid: increases oseltamivir exposure, raising risk of toxicity. - Carbamazepine: induces metabolism, reducing antiviral effectiveness. - Ritonavir: may alter oseltamivir pharmacokinetics, leading to unpredictable levels.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR, requiring coagulation monitoring. - Oral contraceptives: possible reduction in hormonal efficacy, advise additional contraception. - Immunosuppressants: monitor for infection risk and drug levels.